Steward Partners Investment Advisory’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.6K | Buy |
+315
| New | +$20.6K | ﹤0.01% | 2912 |
|
|
2025
Q1 | – | Sell |
-162
| Closed | -$10.6K | – | 4081 |
|
|
2024
Q4 | $10.6K | Hold |
162
| – | – | ﹤0.01% | 3068 |
|
|
2024
Q3 | $11.4K | Hold |
162
| – | – | ﹤0.01% | 2901 |
|
|
2024
Q2 | $10.7K | Hold |
162
| – | – | ﹤0.01% | 2795 |
|
|
2024
Q1 | $11K | Hold |
162
| – | – | ﹤0.01% | 2773 |
|
|
2023
Q4 | $10K | Sell |
162
-819
| -83% | -$50.6K | ﹤0.01% | 2715 |
|
|
2023
Q3 | $57.9K | Sell |
981
-1,902
| -66% | -$112K | ﹤0.01% | 1842 |
|
|
2023
Q2 | $172K | Sell |
2,883
-22,917
| -89% | -$1.37M | ﹤0.01% | 1357 |
|
|
2023
Q1 | $1.51M | Hold |
25,800
| – | – | 0.02% | 549 |
|
|
2022
Q4 | $1.6M | Buy |
25,800
+72
| +0.3% | +$4.47K | 0.03% | 517 |
|
|
2022
Q3 | $1.45M | Sell |
25,728
-225
| -0.9% | -$12.7K | 0.03% | 522 |
|
|
2022
Q2 | $1.66M | Sell |
25,953
-879
| -3% | -$56.2K | 0.03% | 488 |
|
|
2022
Q1 | $1.74M | Sell |
26,832
-23,352
| -47% | -$1.51M | 0.03% | 523 |
|
|
2021
Q4 | $3.34M | Buy |
50,184
+402
| +0.8% | +$26.7K | 0.05% | 348 |
|
|
2021
Q3 | $3.04M | Buy |
49,782
+2,304
| +5% | +$141K | 0.05% | 345 |
|
|
2021
Q2 | $2.94M | Buy |
47,478
+2,298
| +5% | +$142K | 0.05% | 361 |
|
|
2021
Q1 | $2.68M | Sell |
45,180
-5,505
| -11% | -$326K | 0.05% | 365 |
|
|
2020
Q4 | $3.03M | Buy |
50,685
+195
| +0.4% | +$11.7K | 0.07% | 290 |
|
|
2020
Q3 | $2.75M | Buy |
50,490
+4,305
| +9% | +$235K | 0.07% | 264 |
|
|
2020
Q2 | $2.37M | Buy |
46,185
+23,511
| +104% | +$1.21M | 0.07% | 278 |
|
|
2020
Q1 | $1.02M | Sell |
22,674
-1,716
| -7% | -$77K | 0.04% | 385 |
|
|
2019
Q4 | $1.3M | Buy |
24,390
+4,380
| +22% | +$234K | 0.04% | 385 |
|
|
2019
Q3 | $932K | Buy |
20,010
+3,753
| +23% | +$175K | 0.03% | 429 |
|
|
2019
Q2 | $817K | Buy |
+16,257
| New | +$817K | 0.03% | 430 |
|